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Abstract: 30 patients with delayed contrast enhancement in patterns suggestive of myocardial infarctions were reviewed. 
Infarct mass was quantitatively measured using short axis images obtained in the delayed phase of gadopentetate   
administration. Left ventricular mass and ejection fraction were measured using short axis, steady state free precession 
images. A relationship is drawn between increased mass of infarction and decreased left ventricular ejection fraction.  
For each gram of infarct, there is a 0.5 % reduction in ejection fraction (EF = 50 - (0.48 x gm infarcted myocardium);  
r
2= 0.49). For each % increase of infarcted myocardium, there is a 0.67 % reduction in ejection fraction (EF = 50 - (0.67 x 
percent of infarcted myocardium); r
2= 0.39). Left ventricular ejection fraction correlates inversely with the mass of   
myocardium with delayed enhancement on cardiac MRI.  
INTRODUCTION  
  Delayed contrast enhancement MRI (DCE-MRI)   
has gained widespread acceptance as an accurate means   
to delineate myocardial fibrosis. Myocardial fibrosis   
patterns consistent with myocardial infarction are derived 
from patterns with subendocardial to progressive transmural 
involvement in an anatomic distribution consistent   
with coronary anatomy. As cardiac MRI has become   
more commonly utilized, further applications of this   
technique have developed including evaluation of other   
cardiomyopathies. Although several studies have showed   
the validity of DCE for measuring infarct size and   
predicting nonviability, further work is needed to establish 
the significance of quantitative assessment of infarct   
size using DCE-MRI. 
  The ability to predict the left ventricular ejection fraction 
based on infarct volume size adds  a new diagnostic   
dimension to delayed contrast enhanced MRI. This   
retrospective study is performed to assess the quantitative 
relationship between infarct size as defined by DCE and the 
degree of decrease in ejection fraction in order to define 
whether a reliable prediction in the degree of decreased   
systolic function can be made based on quantification of the 
size of the infarct as shown by DCE-MRI.  
METHODS 
Patient Population 
  Thirty consecutive patients from a large, county hospital 
were included in the analysis. Inclusion criteria consisted   
of presence of an infarction in the left ventricle, visible   
on DCE-MRI and completion of the MRI study. Patients 
were included in the study only if the morphology of areas of  
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delayed contrast enhancement conformed to the expected 
shape and distribution of an infarction (e.g. subendocardial 
progressive to transmural delayed enhancement in the   
expected vascular distributions of the coronary arteries [1]. 
Twenty four of the patients were male, the remaining 6 were 
female. The mean age of the population was 54 years, with a 
range from 44 to 68.  
MRI TECHNIQUE 
  Studies were performed between June 21st, 2006   
and April 3rd, 2007. All studies were performed on a GE 
Signa 1.5T field strength MRI unit. Computation of systolic 
function was based on short axis, balanced steady state free 
precession sequences (Fast Imaging Employing Steady State 
Acquisition (FIESTA)). Contiguous 8 mm short axis images 
were obtained during breath-holding and using segmental   
k-space acquisition gated to the cardiac cycle. Ten minutes 
after the intravenous administration of Magnevist (Bayer, 
Wayne, NJ), 0.2 mmol/kg, and delayed contrast enhanced 
contiguous 8 mm short axis images were obtained during 
breath-holding using a gradient-echo inversion recovery
  
sequence with inversion time optimized to null normal   
myocardial signal. Processing was performed on an ADW 
workstation (General Electric, Milwaukee, WI) using Mass 
Analysis Plus (Medis, Leiden, The Netherlands). Regions of 
interest were manually drawn around the left ventricle at end 
systole and end diastole on the functional images (Fig. 1) 
and around the areas of delayed myocardial enhancement 
(Fig.  2). These regions were used to generate quantitative 
functional data including assessment of ejection fraction 
(LVEF), end systolic and end diastolic volumes, stroke   
volumes, assessment of left ventricular (LV) mass and   
myocardial infarct volume. Comparisons were made   
between the size of infarction and the left ventricular   
ejection fraction.  
RESULTS  
  Our analysis shows that there is a predictable, linear   
relationship between infarct size and degree of systolic   36    The Open Cardiovascular Medicine Journal, 2009, Volume 3  Shriki et al. 
dysfunction (Table 1). Two parameters specifically were 
correlated to assess the relationship between infarct size and 
depressed systolic function. 
 
 
 
 
 
Fig. (1). Regions drawn at end-systole and end-diastole. DCE-
MRI sequences were obtained at a time delay of ten to fifteen   
minutes and using an inversion time (TI) of 200 ms. Quantification 
of infarct size was processed on an ADW workstation as well, 
based on short axis images. 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Region drawn around area of infarction. 
  First, we drew a relationship between infarct mass and 
ejection fraction. Infarct mass was shown to correlate with 
ejection fraction according to the following relationship: 
  Ejection Fraction (%) = -0.48 x (grams of infracted myo-
cardium) + 50 r
2= 0.4941. 
  In other words, from a baseline ejection fraction of 50%, 
each gram of myocardium infracted would be expected to 
decrease the ejection fraction by roughly 0.5%. (Fig. 3). 
  Second, we drew a relationship between infarct percent-
age and ejection fraction. Infarct percentage was calculated 
by again deriving an infarct mass as described above   
and dividing the amount of infarcted myocardium by the 
total left ventricular mass. Infarct percentage was shown to 
correlate with ejection fraction according to the following 
relationship: 
  Ejection Fraction (%) = -0.67 x (% mass of infarcted 
myocardium) + 49 r
2 = 0.3919. 
  In other words, from a baseline ejection fraction of 
roughly 50%, each incremental increase in percentage of 
myocardium infarcted would be expected to decrease the 
ejection fraction by 0.66%. (Fig. 4).  
DISCUSSION 
  Ejection fraction is an important factor in assessment   
of cardiovascular morbidity and mortality [1-5]. There is 
indeed, an important relationship between infarct size,   
decreased systolic function, and subsequent cardiovascular 
morbidity and mortality [6, 7]. 
Table 1.  LVEF, Infarct Mass, and Infarct Percent 
LVEF  Infarct Mass (grams)  Infarct % 
26.72 54.58 0.27 
19.33 72.74 0.45 
49.10 6.64 0.05 
17.12 54.88 0.44 
15.53 44.22 0.19 
56.16 1.98 0.02 
48.04 11.67 0.06 
14.63 37.17 0.26 
32.45 21.87 0.20 
37.79 8.81 0.07 
40.22 17.29 0.18 
38.30 24.79 0.17 
14.33 38.95 0.30 
37.86 23.94 0.23 
56.45 19.14 0.16 
17.92 89.72 0.55 
25.89 35.56 0.17 
26.66 58.61 0.42 
35.05 20.32 0.12 
63.57 12.80 0.12 
50.62 46.27 0.28 
16.10 39.12 0.29 
60.60 3.65 0.04 
49.81 26.21 0.22 
26.63 38.67 0.21 
45.00 1.62 0.01 
44.43 12.53 0.11 
19.76 30.82 0.15 
30.91 55.73 0.48 
41.01 16.88 0.17 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Relationship of left ventricular ejection fraction 
(LVEF) to infarct volume. LVEF = -0.48 x grams infracted myo-
cardium + 50, r
2 = 0.4941. 
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Fig. (4). Relationship of LVEF to infarct percent. LVEF = -0.67 
x % infarct mass + 49, r
2 = 0.3919. 
  Previously, infarct size has been measured noninvasively 
by several other imaging modalities and correlated with 
worsened systolic function. This has been employed most 
widely with scintigraphy [8-12], but has also been shown 
with estimations of infarct size based on serum enzyme 
evaluation. [13-15] Efforts to evaluate infarct size by studies 
evaluating motion such as echocardiography usually overes-
timate infarct size, since non-transmural infarctions affecting 
the sub-endocardium will cause disproportionately larger 
areas of wall motion abnormalities [16, 17].  
  MRI more recently been validated in both animal models 
and in humans as demonstrating excellent correlation with 
pathologic size of areas of infarction. The superior spatial 
resolution of MRI allows better evaluation of overall size of 
infarction and can also enable delineation of degree of wall 
thickness involvement in infarction. [18-20]  
  Other studies have shown links between infarct size and 
wall motion abnormalities. Marholdt et al. showed that wall 
motion abnormalities ensue when more than 20% of wall 
thickness is infarcted in a given segment. [21] Beek et al. 
have shown that the likelihood of recovery of function   
diminishes when > 50% of wall thickness is infarcted [22]. 
These investigations have shown the utility of evaluating   
the degree of transmurality of infarctions, which is best 
demonstrated by MRI [23]. 
  This study further supports the link between infarct size 
and ejection fraction. Also, we further show that in addition 
to proportionality, there is a quantifiable, direct relationship 
between the size of the infarct and the degree of systolic   
dysfunction. This is the largest study, to date, to show   
this linkage. To our knowledge, this is also the first study  
to quantify the predictability of systolic dysfunction from 
DCE-MRI. 
  There are several implications from this data that   
this analysis does not directly address. First, it follows   
syllogistically that if infarct size is correlated with worsened 
systolic function and depressed ejection fraction contributes 
to increase cardiac morbidity and mortality, then the amount 
of infarction measured by DCE-MRI may be an important 
indicator of subsequent morbidity and mortality. At our   
institution, data collection is currently underway to better 
evaluate this relationship. 
  Additionally, several outliers in the data sets are present. 
These consist of patients who either had smaller infarct size 
but more severe systolic dysfunction or patients who had 
larger infarcts but relatively preserved function.  
  Although there was heterogeneity in the patient popula-
tion studied herein, it would be helpful to identify patients 
who may lie in the former category, with relatively severe 
systolic dysfunction for the degree of infarct size. This   
patient population would be important to identify for two 
reasons. First, we would posit that in patients with relatively 
small infarct size but severe systolic dysfunction, there may 
be a greater benefit for subsequent revascularization. A   
follow-up study showing a function-DCE mismatch might   
be useful in patients who should be more aggressively   
considered for revascularization. Second, identifying patients 
with a systolic function-DCE mismatch might be related to a 
superimposed cardiomyopathy.  
  Relatively fewer patients were identified with relatively 
with larger infarct size had preserved systolic function.   
The finding of few patients in this latter category further 
underscores that worsened DCE is associated with more   
deteriorated function. Further study could be directed at   
optimization of function in the setting of large infarctions.  
A benchmark for the utility of treatment options would be 
pushing the patient rightward in the direction of the abscissa 
on the graphs presented, e.g. achieving improvements in 
systolic function in the face of larger infarctions.  
  Finally, another implication of the data presented is in  
the better reliability of the relationship between infarct size 
and ejection fraction compared with infarct percentage and 
ejection fraction. Based on this relatively small study sample 
size, it is likely that infarct size is a better predictor of func-
tional impairment than infarct percentage. This makes sense 
since in calculating infarct percentage; the denominator used 
is left ventricular mass. Although increased left ventricular 
mass and remodeling may be useful in order to preserve   
systolic function, beyond a certain point, enlargement of the 
left ventricle becomes dysfunction. In patients with an   
enlarged left ventricle, it is suspected that an infarction might 
result in an even greater impairment in contractility. This 
contention is born out in the fact that overall infarct size, 
rather than infarct percentage is a more reliable predictor of 
left ventricular dysfunction. 
  We acknowledge several limitations in this study.   
Specifically, there was some heterogeneity in the patient 
populations. Many of the patients were imaged at least   
one month after the date of infarction. However, for many 
patients, the date of infarction was difficult to ascertain,   
by history. Hombach et al. [23] have shown that functional 
recovery is maximized at one month after infarction. 
  An additional limitation of this study is the possible   
overlap in patients who have ischemic and other, superim-
posed etiologies for cardiomyopathy. All of the studies   
included in this analysis were screened by an experienced 
cardiac MRI reader to ensure that the areas of delayed   
enhancement had morphology consistent with infarction. On 
the other hand, however, it is impossible to ensure that the 
patients included do not have a superimposed non-ischemic 
cardiomyopathy.  
CONCLUSIONS 
 Percent myocardium with delayed enhancement   
correlates inversely with ejection fraction in an incremental 
manner, where from a baseline ejection fraction of 50%, 
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each gram of myocardium infracted is correlated with a   
decrease in left ventricular ejection fraction of 0.5%. 
REFERENCES 
[1]  van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman 
ML, Hillege H, Lie KI. Comparison between New York Heart   
Association classification and peak oxygen consumption in the   
assessment of functional status and prognosis in patients with mild 
to moderate chronic congestive heart failure secondary to either 
ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 
70: 359-63.  
[2]  Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortal-
ity in chronic congestive heart failure secondary to idiopathic   
dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 
634-8.  
[3]  Juillière Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, 
Cherrier F. Additional predictive value of both left and right   
ventricular ejection fractions on long-term survival in idiopathic   
dilated cardiomyopathy. Eur Heart J 1997; 18: 276-80.  
[4]  Hallstrom A, Pratt CM, Greene HL, et al. Relations between heart 
failure, ejection fraction, arrhythmia suppression and mortality: 
analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll 
Cardiol 1995; 25: 1250-7.  
[5]  Pernenkil R, Vinson JM, Shah AS, Beckham V, Wittenberg C, 
Rich MW. Course and prognosis in patients  70 years of age with 
congestive heart failure and normal versus abnormal left ventricular 
ejection fraction. Am J Cardiol1997; 79: 216-9.  
[6]  The Multicenter Post infarction Group. Risk stratification and 
survival after myocardial infarction. N Engl J Med 1983; 309: 331-
6.  
[7]  White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, 
Wild CJ. Left ventricular end-systolic volume as the major   
determinant of survival after recovery from myocardial infarction. 
Circulation1987; 76: 44-51.  
[8]  Van de Werf F. Discrepancies between the effects of coronary 
reperfusion on survival and left ventricular function. Lancet 1989; 
1: 1367-9.  
[9]  Silverman KJ, Becker LC, Bulkley BH, et al. Value of early   
thallium-201 scintigraphy for predicting mortality in patients with 
acute myocardial infarction. Circulation 1980; 61: 996-1003.  
[10]  Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, 
Weisfeldt M. Comparison of early thallium-201 scintigraphy   
and gated blood pool imaging for predicting mortality in   
patients with acute myocardial infarction. Circulation 1983; 67: 
1272-82.  
[11]  Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, 
Rumberger JA. Relations of initial infarct size to extent of left   
ventricular remodeling in the year after acute myocardial   
infarction. J Am Coll Cardiol 1995; 25: 567-73. 
[12]  Botvinick EH, Perez-Gonzalez JF, Dunn R, Ports T, Chatterjee K, 
Parmley W. Late prognostic value of scintigraphic parameters of 
acute myocardial infarction in complicated myocardial infarction 
without heart failure. Am J Cardiol 1983; 51: 1045-51.  
[13]  Hackel DB, Reimer KA, Ideker RE, et al. Comparison of enzy-
matic and anatomic estimates of myocardial infarct size in man. 
Circulation 1984; 70: 824-35.  
[14]  Smith JL, Ambos HD, Gold HK, et al. Enzymatic estimation of 
myocardial infarct size when early creatine kinase values are not 
available. Am J Cardiol 1983; 51: 1294-300. 
[15]  Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed-
contrast enhancement to irreversible injury, infarct age, and con-
tractile function. Circulation 1999; 100: 1992-2002. 
[16]  Force T, Kemper A, Perkins L, Gilfoil M, Cohen C, Parisi AF. 
Overestimation of infarct size by quantitative two-dimensional 
echocardiography: the role of tethering and of analytic procedures. 
Circulation 1986; 73: 1360-8.  
[17]  Homans DC, Pavek T, Laxson DD, Bache RJ. Recovery of   
transmural and subepicardial wall thickening after subendocardial 
infarction. J Am Coll Cardiol 1994; 24: 1109-16.  
[18]  Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. 
Contrast-enhanced magnetic resonance imaging of myocardium   
at risk: distinction between reversible and irreversible injury 
throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-91. 
[19]  Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging 
technique for the visualization of myocardial infarction. Radiology 
2001; 218: 215-23. 
[20]  Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of 
chronic infarct size measurement by contrast-enhanced magnetic 
resonance imaging. Circulation 2002; 106: 2322-7. 
[21]  Mahrholdt H, Wagner A, Parker M, et al. Relationship of contrac-
tile function to transmural extent of infarction in  patients with 
chronic coronary artery disease. J Am Coll Cardiol 2003; 42: 505-
12. 
[22]  Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-
enhanced magnetic resonance imaging for the prediction of   
regional functional improvement after acute myocardial infarction. 
J Am Coll Cardiol 2003; 42:  895-901. 
[23]  Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocar-
dial infarction regarding cardiac structure and function and   
their prognostic significance as assessed by magnetic resonance 
imaging. Eur Heart J 2005; 26: 549-57.  
 
 
Received: April 13, 2009  Revised: April 20, 2009  Accepted: April 21, 2009 
 
© Shriki et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 